Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs11575248 | chr12:56735990 | G/T | 9.68E-8 | 178 | 25.17 | 29.13 | 0.8 | KM Plot |
PCPG | rs115804187 | chr7:158652756 | T/G | 0 | 176 | 25.53 | 19.83 | 3.17 | KM Plot |
PCPG | rs11583130 | chr1:56400111 | A/G | 4.65E-5 | 175 | 25.47 | 26.27 | 15.8 | KM Plot |
PCPG | rs11586900 | chr1:244148851 | A/T | 0.000372 | 170 | 26.65 | 24.1 | 15.8 | KM Plot |
PCPG | rs11591052 | chr1:244158772 | G/A | 0.000262 | 176 | 27.6 | 20.17 | 15.8 | KM Plot |
PCPG | rs11592211 | chr10:1076470 | A/G | 1.28E-5 | 175 | 24.62 | 29.57 | 13.38 | KM Plot |
PCPG | rs11593181 | chr10:131555141 | A/T | 6.44E-6 | 178 | 10.3 | 28.35 | 25.17 | KM Plot |
PCPG | rs115979802 | chr2:176205228 | T/C | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |
PCPG | rs115995862 | chr1:36924628 | G/T | 8.21E-5 | 175 | 25.53 | 25.97 | 10.3 | KM Plot |
PCPG | rs1160393 | chr2:209979254 | T/C | 5.41E-8 | 176 | 20.03 | 23.53 | 27.27 | KM Plot |
PCPG | rs11606517 | chr11:90016813 | G/T | 0.000472 | 173 | 24.53 | 27.4 | 19.78 | KM Plot |
PCPG | rs11608814 | chr12:6597129 | C/T | 0.000303 | 175 | 25.42 | 25.97 | 16.3 | KM Plot |
PCPG | rs116097911 | chr2:121545543 | C/T | 0.000238 | 175 | 25.53 | 24.37 | 59.77 | KM Plot |
PCPG | rs11610712 | chr12:6612883 | G/C | 0.000292 | 174 | 24.53 | 26.27 | 19.87 | KM Plot |
PCPG | rs116312294 | chr2:121545619 | T/G | 0.000214 | 177 | 25.53 | 24.37 | 59.77 | KM Plot |